and the dose-response curve was assessed by only one index, either the threshold concentration (TC) or the provocative concentration (PC) of the stimulus causing a predetermined fall in FEV1. We decided to study histamine dose-response curves in clinically stable asthmatic subjects to assess the reproducibility and sensitivity of different measurements of bronchoconstriction, using different indices from the dose-response curves.
measurements and more reproducible than any of the TC values. The 95% confidence intervals based on a single determination of R varied from 52% to + 74% change/log histamine concentration. Both sGL and Vmax40, detected the bronchoconstrictor response assessed by PC and TC at a significantly lower histamine concentration than FEVy (p < 0-01 and p < 0-05 respectively). PC and TC results showed a significant correlation, but neither were correlated with R.
After Dautrebande and Philippot' introduced nonallergic bronchial inhalation challenges in 1941, Tiffeneau,2 Curry,3 and De Vries4 used the tests for clinical purposes. Attempts to standardise the procedure have been made,56 but so far only a few studies of reproducibility have been published.7-9 In these studies the forced expiratory volume in one second (FEVy) only was used to monitor response, and the dose-response curve was assessed by only one index, either the threshold concentration (TC) or the provocative concentration (PC) of the stimulus causing a predetermined fall in FEV1. We decided to study histamine dose-response curves in clinically stable asthmatic subjects to assess the reproducibility and sensitivity of different measurements of bronchoconstriction, using different indices from the dose-response curves.
Methods

PATIENTS
We studied 18 patients (five male, thirteen female) aged 19-55 years (table 1) . All satisfied the criteria for asthma of the American Thoracic Society10 and were clinically stable at the time of study, with no nocturnal awakening due to asthma and minimum symptoms by day. None of the subjects reported any respiratory infection in the six weeks preceding the test. Patients with immediate positive skin reactions to animal dander and pollen had had no exposure to these allergens in the month preceding the study. At the time of study all subjects were taking bronchodilator medication on a regular basis or less frequently, and 12 were taking inhaled beclomethasone regularly. Bronchodilators were withheld before the inhalation tests for the time interval suggested by the special committee of the American Academy of Allergy.5 Written consent was obtained Reference values were taken from Goldman and Becklake'5 and from Chemiack'6 for FEV, and Vmax5ee respectively. STUDY 
DESIGN
Subjects were studied on two (10 subjects), three (one subject), or four (seven subiects) occasions, at the same time of day on separate days, with a maximum interval between studies of two weeks. Baseline measurements of RL and thoracic gas volume (TGV) were carried out to derive specific lung conductance (sGL), and partial and complete maximum expiratory flow-volume curves were then produced. Subjects then inhaled phosphate buffer saline from a Wright's nebuliser (output 0-15 ml/ min) through a face mask for two minutes,6-a breathing tidally at a rate of 14 breaths a minute in time with a metronome. RL and TGV were measured one to two minutes after the end of nebulisation. The subject then performed two maximum partial expiratory manoeuvres, initiated from the endinspiratory position. These were followed immediately by two complete forced expiratory manoeuvres initiated from TLC. All measurements were completed within three minutes of the end of nebulisation. This interval is within the period of the maximum bronchoconstrictor effect of histamine, which has been estimated to last for a mean of 16-8 minutes (range 4-37 min).'7 Two inhalations of diluent were followed by increasing concentrations of histamine, from 0-03 to a maximum dose of 32 mg/ml. The histamine was given at five-minute intervals to prevent any cumulative effect of histamine.7 The test was stopped when the patient showed a 30-50% fall in FEV,.
ANALYSIS OF DOSE-RESPONSE CURVES Dose-response curves were drawn on a semi-log scale, the abscissa representing the concentration and the ordinate-the percentage change in each measurement. The following indices were obtained from each dose-response curve: (1) TC-the concentration of histamine which produced a change in excess of 2 SD from mean post-diluent values (four post-diluent values for FEV, and maximum flows and 10 post-diluent values for sGL): for the 10 subjects who made only two visits there were insufficient measurements to calculate TC for sGL; (2) PC-the concentration of histamine causing a predetermined fall in each measurement, 20% for FEV1 (PC20) and 40% for the other measurements (PC40). These percentages were well outside the range of measurements seen after inhalation of diluent (table 2); (3) reactivity (R)-the slope of the A one-way analysis of variance was used to compare within-subject and between-subject variance for log TC, log PC, and R, calculating intraclass correlation Linear regression analysis was used to compare log TC, log PC, and R at each visit.
Results
BASELINE FUNCTIONAL RESULTS
On the initial assessment 14 subjects had an FEV, above 80% of the predicted value, while only four had a Vmaxs,, above 80% predicted. The difference in FEV, between assessments was within 10% for each subject; differences in sGL, Vmax,5c, and Vmax4Op were within 50%.
REPRODUCIBILITY OF DOSE-RESPONSE CURVES
The results for reproducibility derived from the one-way analysis of variance are listed in table 3. The F value and intraclass correlation show that between-subject variance was always larger than within-subject variance. The values of intraclass correlation (that is, the proportion of total variance due to real subject differences as opposed to measurement error) were satisfactory. Results of the 95 % confidence interval for the overall mean over subjects and of the 95 % confidence interval for subjects based on a single determination are also given in table 3. These results are expressed as single twofold concentration differences since doubling concentrations of histamine were nebulised (see under "Methods"). The 95% confidence interval of PC2o-FEV, based on a single determination was the observed value ± 1-59 two-fold concentration difference (that is, ±3*18-fold difference). The range for PC20 for FEV, was smaller than the ranges obtained for PC with other measurements. The confidence intervals for PC were smaller than those obtained for TC. The 95 % confidence intervals of R based on a single determination were the observed values ±52-±74 (% change/log histamine concentration), depending on the measurement. Vmax.0c 
Discussion
In this study we assessed the reproducibility of different ways of measuring bronchoconstriction in response to inhaled histamine. We also evaluated the sensitivity of several indices used to monitor the induced bronchoconstriction. This approach stems from the proposals by Orehek22 and other workers that the complete dose-response curves should be studied rather than a single point. The use of measurements other than the FEV, has also been suggested. 2325 We found that the concentration of histamine causing a 20% fall in FEV, (PC20)6-8 was the most reproducible index, a 95 % confidence interval based on a single determination being the observed value + 1-59 two-fold concentration difference (+ 3*18-fold difference in PC20). This range is larger than that described by Ryan and coworkers.8 We used a similar method of nebulisation and baseline FEV1 varied less than 10% in both studies. There was a similar difference in reproducibility between two studies from the same group of investigators using a similar method of nebulisation.78 The reproducibility of airway hyperreactivity may therefore vary as a result of differences between the subjects studied. As suggested by Ryan and colleagues,8 this emphasises the importance of baseline data in studies which examine changes in PC2 FEV. In our study the reproducibility of TC was less satisfactory than that of PC.
Some of the theoretical advantages of more complete characterisation of the dose-response curve22 are therefore countered by the fact that these measurements are less reproducible than is PC. The PC2,FEv has been shown to correlate with the clinical state '9 and need for medication of asthmatic subjects,26 whereas the clinical relevance of reactivity is unknown. Orehek and colleagues claimed that reactivity distinguished normal from asthmatic subjects.26 Their dose-response curves, however, were drawn on an arithmetic rather than the more usual scale. In another study using dose-response curves, the reactivity of normal subjects did not differ from that of asthmatic patients.27 Beauprd and Malo found no correlation between reactivity and the clinical state of asthma, '9 while in our study and others '4 PC2oFEV of less than 8 mg/ml, whereas all the asthmatic patients with symptoms had lower values.6
The same group of investigators,3' however, recently described a grey zone from 2 to 20 mg/ml: asthmatic subjects with such responses may have no symptoms, normal diurnal variation of peak flow rate, and no appreciable induced bronchoconstriction unless exposed to a vigorous stimulus. 32 Orehek et al found that both TC (sensitivity) and reactivity differed between normal and asthmatic subjects, though there was considerable overlap.20 In a smaller group of subjects PC2 FEv appeared to be more specific than indices using sGL and maximum partial expiratory flow rates in distinguishing normal from asthmatic responses.32 Population studies are needed to evaluate the ability of these various indices to separate normal and asthmatic patients. 
